Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › GMAB
SUPERSTRING CAPITAL MANAGEMENT LP position in GMAB
GENMAB A/S · Health Care
SUPERSTRING CAPITAL MANAGEMENT LP reported holding 430,600 shares of GMAB (GENMAB A/S) in its Q2 2026 13F filing — a position valued at US$11.8M, representing 7.47% of its reported portfolio and ranking #3 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed GMAB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SUPERSTRING CAPITAL MANAGEMENT LP's GMAB position evolved
SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in GMAB in Q4 2025 at 29,162 shares (US$898K). The position peaked in Q2 2026 at 430,600 shares, worth US$11.8M. Across 3 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 430,600 shares valued at US$11.8M — an increase of 233,891 shares quarter over quarter.. Notable position changes include a 575% increase in Q1 2026 (shares rose 2% over the following quarter), a 119% increase in Q2 2026 (shares rose 30% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 29.16K | $898.19K | New |
| Q1 2026 | 196.71K | $5.28M | Add |
| Q2 2026 | 430.60K | $11.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMAB and 13F data
GMAB (GENMAB A/S) is a Health Care company. 31 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$360.8M), Orbis Allan Gray Ltd (US$312.3M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$188.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMAB
- Paradigm Biocapital Advisors LP 13.13M sh · $360.77M · Q2 2026
- Orbis Allan Gray Ltd 11.37M sh · $312.28M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 6.87M sh · $188.58M · Q2 2026
- Sofinnova Investments, Inc. 4.05M sh · $111.12M · Q2 2026
- HARDING LOEVNER LP 3.09M sh · $86.90M · Q2 2026
- Deep Track Capital, LP 3.00M sh · $82.41M · Q2 2026
More on SUPERSTRING CAPITAL MANAGEMENT LP
FAQ
How long has SUPERSTRING CAPITAL MANAGEMENT LP held GMAB?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed GMAB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in GMAB?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 430.60K shares of GMAB (GENMAB A/S), valued at $11.83M, representing 7.47% of its reported portfolio and ranking #3.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling GMAB?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in GMAB. The position peaked in Q2 2026 at 430.60K shares.
Which other funds hold GMAB?
Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, DEERFIELD MANAGEMENT COMPANY, L.P., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.